Shimon Peres to raise funds for Israeli brain research

Nonprofit organization will seek to shift the emphasis of research in Israel toward brain research through conventions, steering committees and, most importantly, by raising money.

May 23, 2011 22:46
1 minute read.
President Shimon Peres

Shimon Peres 311. (photo credit: Marc Israel Sellem/The Jerusalem Post)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


President Shimon Peres announced Monday at the ILSI-Biomed Conference 2011 he will set up a nonprofit organization to support brain research in Israel.

It will be headed by Dr. Rafi Gidron, a cofounder of Chromatis Networks, which was sold to Lucent for over $4 billion in 2000. He is currently involved in volunteer work and invests in clean-tech companies through his firm Precede Technologies.

The aim of the proposed NPO will be to shift the emphasis of research in Israel toward brain research through conventions, steering committees and, most importantly, by raising money.

The NPO will identify the most interesting and important subfields in brain research where Israel has the greatest comparative advantage and raise capital to support basic and applied research in them via a range of research institutes, NPOs and possibly young commercial companies.

“We intend to replicate our achievements in nanotechnology in neuro-technology, but the scale will be much greater and more impressive,” Peres told Globes.

“Israel lives on its brain,” he said. “This is not a onetime thing; it is something renewed constantly and ever more powerfully. We’re now embarking on the fourth revolution. The first were the agricultural, industrial and information revolutions, and now comes the revolution of the brain. This is a problem that Israel devotes itself to solving as quickly as possible and as strongly as possible.”

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection